Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2003-10-30
2009-10-13
Prouty, Rebecca (Department: 1652)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S094400, C435S192000
Reexamination Certificate
active
07601366
ABSTRACT:
The molecular mechanisms of peroxisome biogenesis have begun to emerge: in contrast, relatively little is known about how the organelle functions as cells age. The present inventors characterized age-related changes in peroxisomes of human cells and showed that aging compromises peroxisomal targeting signal 1 (PTS 1) protein import, with the critical antioxidant enzyme, catalase, especially affected. The number and appearance of peroxisomes are altered in these cells, and the organelles accumulate the PTS1-import receptor, Pex5p, on their membranes. Concomitantly, cells produce increasing amounts of the toxic metabolite, H2O2, and this increased load of reactive oxygen species (ROS) may further reduce peroxisomal protein import and exacerbate the effects of aging. Disclosed are novel compositions and methods for restoring catalase in peroxisomes by use of targeted catalase modified at its C-terminus and/or N-terminus, optionally in combination with polypeptides which promote cellular uptake of proteins, to prevent or overcome the changes that follows aging or that are associated with a number of diseases or disorders.
REFERENCES:
patent: 5824469 (1998-10-01), Horwitz et al.
patent: 6057136 (2000-05-01), Bower et al.
patent: 6159710 (2000-12-01), Fraser et al.
Sheik et al. (PNAS 95 : 2961, 1998).
Trelease, R.N. et al. Rat Liver Catalase is Sorted to Peroxisomes By Its C-Terminal Tripepeptide Ala-Asn-Leu Not By the Internal Ser-Lys-Leu Motif. Eur. J. Cell Biol.71: 248-258. (Nov. 1996).
Fuijiwara, C. et al. “Catalase-less Peroxisomes”. J. Biol. Chem. 275(47): 37271-37277 (Nov. 2000).
G.Lametschwandtner et al. “The Difference in Recognition of Terminal Tripeptides as Peroxisomal Targeting Signal 1 Between Yeast and Human Is Due to Different Affinities of Their Receptor Pex5p to the Cognate Signal and to Residues Adjacent to It”, J. Biol. Chem. vol. 273(50):33635-33643. (Dec. 1998).
Terlecky Stanley R.
Walton Paul A.
Browdy & Neimark, P.L.L.C.
Prouty Rebecca
Wayne State University
LandOfFree
Promotion of peroxisomal catalase function in cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promotion of peroxisomal catalase function in cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promotion of peroxisomal catalase function in cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107595